Lentiviral backbone-based hepatitis B virus replicon-mediated transfer favours the establishment of persistent hepatitis B virus infection in mice after hydrodynamic injection-Reference-Cited by-同舟云学术

Lentiviral backbone-based hepatitis B virus replicon-mediated transfer favours the establishment of persistent hepatitis B virus infection in mice after hydrodynamic injection

Published:2014-01 Issue: Volume:101 Page:68-74
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Chuai Xia,Wang Wen,Chen Hong,Deng Yao,Wen Bo,Tan Wenjie

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference30 articles.

1. A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice;Buchmann;Vaccine,2013

2. Enhanced effect of DNA immunization plus in vivo electroporation with a combination of hepatitis B virus core-PreS1 and S-PreS1 plasmids;Chen;Clin. Vaccine Immunol.,2011

3. Optimisation of prime-boost immunization in mice using novel protein-based and recombinant vaccinia (Tiantan)-based HBV vaccine;Chen;PLoS ONE,2012

4. Persistent hepatitis B viral replication in a FVB/N mouse model: impact of host and viral factors;Chen;PLoS ONE,2012

5. Hepatitis B virus transgenic mice: models of viral immunobiology and pathogenesis;Chisari;Curr. Top. Microbiol. Immunol.,1996

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-pressure Hydrodynamic Injection as a Method of Establishing Hepatitis B Virus Infection in Mice;Comparative Medicine;2024-02-01

2. HBV precore G1896A mutation promotes growth of hepatocellular carcinoma cells by activating ERK/MAPK pathway;Virologica Sinica;2023-10

3. Hydrodynamic Delivery: Characteristics, Applications, and Technological Advances;Pharmaceutics;2023-03-31

4. Modeling Hepatotropic Viral Infections: Cells vs. Animals;Cells;2021-07-08

5. Animal models for the study of human hepatitis B and D virus infection: New insights and progress;Antiviral Research;2020-10